Alexion Pharmaceuticals, Inc. · 1 month ago
Senior Director Network Strategy
Gaithersburg, Maryland, United States of America
Full-time
Onsite
Director/Executive
$167K/yr - $251K/yr
10+ years expAstraZeneca is a company that transforms opportunities into life-changing medicines through entrepreneurial thinking and strategic vision. The Senior Director Network Strategy will drive the strategic evolution of the biologics manufacturing network, ensuring the company is positioned to deliver breakthrough therapies to patients worldwide.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Develop and execute comprehensive network strategies for the biologics drug substance platform across AstraZeneca's global operations
Lead strategic evaluations of our supply chain footprint, including make-vs-buy decisions and contract manufacturing partnerships
Drive capacity planning by analyzing portfolio demand and aligning supply options to meet current and future requirements
Collaborate cross-functionally with Biologics Global Technical Operations, BPD, Global Engineering, and GSSDs to integrate emerging pipeline technologies into our network strategy
Evaluate and optimize asset utilization, identifying opportunities for network optimization and efficiency improvements
Design the biologics drug substance network to support AstraZeneca's exciting pipeline of breakthrough therapies and emerging modalities
Provide strategic input on capital allocation decisions with direct accountability for CapEx prioritization within your platform
Assess financial implications of strategic options, analyzing impact on CapEx, OpEx, and inventory optimization
Represent Global Operations in senior cross-functional decision-making forums
Partner closely with Global Biologics Operations and Biopharmaceutical Development teams
Influence product development processes to ensure effective supply chain design for new biologics
Act as an external ambassador for AstraZeneca's Global Operations function
Challenge and influence senior stakeholders across the organization when strategic alignment is needed
Qualification
Required
10-15 years in biologics manufacturing, supply chain, or strategic operations roles
Proven track record in leading cross-functional teams and driving strategic initiatives
Expertise in biologics drug substance manufacturing processes and technologies
Strong background in supply chain design, capacity planning, and network optimization
Experience in pharmaceutical product development processes and regulatory environments
Strategic thinking: Scenario planning, long-range strategy development, and complex problem-solving
Financial acumen: Business case development, capital allocation, and P&L impact assessment
Leadership: Matrix team management, stakeholder influence, and change management
Communication: Executive-level presentation skills and ability to articulate complex strategies
Industry knowledge: Comprehensive understanding of pharmaceutical/biotech operations and global regulatory landscape
Benefits
Various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles.
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans.
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
1001-5000 employees
H1B Sponsorship
Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (49)
2024 (57)
2023 (51)
2022 (29)
2021 (27)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Frederic Chereau
SVP, Strategy and Business Development
Imran Shakur
Director, IRT and Technology Lead
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase